At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Mar 5, 2026 at 16:01 ET
Corvus Pharmaceuticals announced plans to host a conference call on March 12, 2026, to discuss its fourth quarter 2025 financial results and provide a business update. The press release contains no actual financial data, guidance, or material operational updates, only logistical details for the upcoming earnings call.
- Corvus Pharmaceuticals will report Q4 2025 financial results on March 12, 2026.
- The company will host a conference call and webcast at 4:30 pm ET.
- No financial results, metrics, or business updates were disclosed in this release.
- The company remains in clinical-stage development with soquelitinib in Phase 3 for PTCL and Phase 1 for atopic dermatitis.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access